Summary The concept that genetic changes accumulate during development and progression of cancer is widely accepted. Frequent allelic losses at chromosome 13q have been found in hepatocellular carcinomas (HCCs), and a known tumour-suppressor at 13ql4, the retinoblastoma (RB) gene, is thought to be the target of those events. However, no strong evidence has emerged to support a significant role of RB during hepatocarcinogenesis. To (Wang and Roger, 1988; Buetow et al., 1989; Tsuda et al., 1990; Ding et al., 1991; Fujimori et al., 1991; Murakami et al., 1991; Simon et al., 1991; Walker et al., 1991; Emi et al., 1992 Emi et al., , 1993 Nishida et al., 1992; Sugimura, 1992; Yeh et al., 1994). However, the precise molecular mechanism of development and/or progression of HCCs still remains unclear.
The genesis of human cancers is generally a multistep process reflecting cumulative genetic alterations that include activation of oncogenes or inactivation of tumour-suppressor genes. We and others have reported losses of heterozygosity in hepatocellular carcinomas (HCCs) and implied the presence of tumour-suppressor genes on chromosomes lp, 4q, 5q, 8p, lIp, 13q, 16q and 17p (Wang and Roger, 1988; Buetow et al., 1989; Tsuda et al., 1990; Ding et al., 1991; Fujimori et al., 1991; Murakami et al., 1991; Simon et al., 1991; Walker et al., 1991; Emi et al., 1992 Emi et al., , 1993 Nishida et al., 1992; Sugimura, 1992; Yeh et al., 1994) . However, the precise molecular mechanism of development and/or progression of HCCs still remains unclear.
LOH on chromosome 13q has been observed frequently in primary cancers of the lung (Weston et al., 1989) , breast (Lee et al., 1988 ), bladder (Cairns et al., 1991 , ovary (Sato et al., 1991) and liver (Wang and Roger, 1988; Murakami et al., 1991; Walker et al., 1991; Nishida et al., 1992) . The RB gene, a gene responsible for retinoblastoma, located at 13q14, is thought to be the most likely candidate involved in the carcinogenesis of these cancers. However, one report has suggested that the RB gene is probably not the target of the frequent allelic deletions on chromosome 1 3q in ovarian cancers (Kim et al., 1994 (Sato et al., 1990 ).
LOH analysis All 13 markers used in the present study represented polymorphic CA-repeat microsatellite markers: D13S217, D13S260, D13S267, D13S218, D13S263, D13S126, D13S270, D13S172, D13S269, D13S170, D13S265, D13S159 and D13S158 (Gyapay et al., 1994; Wooster et al., 1994; Zhang et al., 1994 , 1994) . With respect to pathological data of tumours, LOH on 13q was significantly higher in moderately or poorly differentiated types (26 of 63 informative cases) than in well-differentiated or early carcinomas (2 of 24 cases) (P = 0.002 by Fisher's exact test). Similarly, LOH of 1 3q was higher in T3/T4 tumours (15 of 33 cases) than in TI (2 of 13 cases) or T2 (11 of 41 cases) tumours.
Discussion
The deletion map constructed in this study implies that two separate regions on chromosome 13q contain HCC-associated tumour-suppressor genes. The region between D13S263 and D13S172 covers a genetic distance of about 15 cM (Gyapay et al., 1994) Wooster et al., 1994; Zhang et al., 1994) . The other commonly deleted region is 23 cM in extent (Gyapay et al., 1994) . Although LOH on chromosome 1 3q is a frequent feature of HCCs (Wang and Roger, 1988; Murakami et al., 1991; Walker et al., 1991; Nishida et al., 1992) , somatic mutation of the RB gene seems to be rare in those tumours; Zang et al. (1994) detected somatic mutations of RB in only two of 13 HCCs with LOH of 13q and/or lack of RB protein expression. Some investigators have shown that allelic losses on chromosome 1 3q tend to occur more frequently in advanced HCCs, being apparently associated with progression of the tumours (Murakami et al., 1991; Nishida et al., 1992) . Our data also supported these previous findings.
The results presented here suggest that the RB gene may still be a candidate to play a role during the progression of HCCs, although somatic mutation of RB so far detected in HCCs is rare. However, some of our tumour samples retained heterozygosity in the vicinity of the loci including the RB gene, but had lost alleles in a more proximal region that is likely to include BRCA2, a hereditary breast cancer gene that has been linked to markers within a 6 cM interval on 13ql2-13 (Wooster et al., 1994) . As the majority of the HCCs examined here lost a relatively large chromosomal segment, including both the commonly deleted regions, it is unclear whether LOHs in those tumours reflect inactivation of the tumour-suppressor gene(s) in the proximal region, in the distal region or in both regions. However, our findings indicate that at least two genes on chromosome 13q are likely to function as tumour suppressors in the hepatic cell.
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